Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Analytikerkommentar

NeoDynamics - Long term financing

Af Claus ThestrupCEO, Sweden
NeoDynamics

NeoDynamics - Long term financing, intends to carry out a Rights Issue of units for an initial amount of up to approximately SEK 72 million to finance commercialization and marketing activities in the USA and Europe. 

Prospectus will be published around the 31st. of July. The EGM takes place the 27th. of July - 2023.

Until the issue is carried out, Gryningskust, Rentability Sweden AB and Formue Nord Markedsneutral A/S will provide NeoDynamics with a loan of SEK 15,5 mio.

The rights issue is backed by largest shareholders, board of directors and management by 80%.

The EGM takes place the 27th. of July - 2023.

Read full announcement here:  Rights issue

Disclaimer:

HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. /ANALYST Claus Thestrup 8:00 AM 06-26-2023.

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.

Læs mere på virksomhedsside
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.